Ryvu Therapeutics SA
WSE:RVU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
PL |
|
C
|
China High Speed Transmission Equipment Group Co Ltd
XMUN:BGR
|
KY |
|
I
|
Ipopema Securities SA
WSE:IPE
|
PL |
|
B
|
Black Rock Coffee Bar Inc
NASDAQ:BRCB
|
US |
|
G
|
Global Payments Inc
F:GLO
|
US |
Intrinsic Value
Is RVU undervalued or overvalued?
See the intrinsic value estimate for Ryvu Therapeutics SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
RVU looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with RVU’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Ryvu Therapeutics Does
Ryvu Therapeutics is a biotechnology company that discovers and develops medicines for cancer. Its work centers on small-molecule drugs and other targeted therapies designed to interfere with the biology that helps tumor cells grow and survive. The company does not sell everyday products; it builds a pipeline of experimental drug candidates and advances them through laboratory testing and clinical trials.
- Headquarters
- Poland PL
- Employees
- 186
- IPO date
- Jul 14, 2011
Revenue & Expenses Breakdown
Ryvu Therapeutics SA
Earnings Waterfall
Ryvu Therapeutics SA
The intrinsic value for Ryvu Therapeutics SA (RVU) under the Base Case is hidden PLN.
Compared with the current market price of 17.7 PLN, the stock appears hidden.